Inpharmus – Turkish Quality in Specialized Medicine
Inpharmus
Inpharmus is a pharmaceutical company founded in Istanbul in 2013 as TRPharm and renamed Inpharmus in 2025. Its Turkish legal entity is Inpharmus İlaç Sanayi ve Ticaret A.Ş., based in the Şişli district of Istanbul. The company also has offices in Zug, Switzerland (Inpharmus AG) and Dubai.
Inpharmus works as a commercialisation partner, bringing medicines from innovative biopharmaceutical companies to markets in Europe, the Middle East, North Africa, Türkiye and the CIS. Its focus areas are oncology, haematology and rare diseases, including neurological, metabolic and autoinflammatory disorders. Partners named by the company include Servier, Sobi, Chiesi and PTC Therapeutics.
Unifarm carries Inpharmus's Wilentin (trientine), a copper-chelating agent for Wilson's disease.